Skip to main content

Do different genders experience PsA differently? There has been a lot of talk lately about the difference in the way m

Social Author Name
Dr. John Cush
Tweet Content
Do different genders experience PsA differently? There has been a lot of talk lately about the difference in the way male and female PsA patients experience their disease. Dr. Petryna ( @DrPetryna) weighs in. #ACR22 https://t.co/nPHf2fR6gQ https://t.co/CcO2gwgh3Y

mTORC1 as a Driver of Inflammation in sJIA Connecting Pathogens of sJIA and MAS Dr. Olga Petryna discusses Abstract 00

Social Author Name
Dr. John Cush
Tweet Content
mTORC1 as a Driver of Inflammation in sJIA Connecting Pathogens of sJIA and MAS Dr. Olga Petryna discusses Abstract 0004 presented at #ACR22 Abstract 0004: mTORC1 Drives the Spectrum of Pathology in Systemic JIA and Macrophage Activation Syndrome https://t.co/XLbchHGG6w https://t.co/h5KArPYrPZ
Steroid injections worsen knee arthritis

Two studies comparing injections commonly used to relieve the pain of knee osteoarthritis found that corticosteroid injections were associated with the progression of the disease. Results of both studies were presented today at the annual meeting of the Radiological Society of North America (RSNA).

Can you use the BASDAI in Pregnancy? Dr. Eric Dein ( @ericdeinmd) discusses abstract 0374 presented at #ACR22 Converg

Social Author Name
Dr. John Cush
Tweet Content
Can you use the BASDAI in Pregnancy? Dr. Eric Dein ( @ericdeinmd) discusses abstract 0374 presented at #ACR22 Convergence in Philadelphia, PA. Abstract 0374: The BASDAI Index During Pregnancy. https://t.co/UB8ZGyQ6mz https://t.co/tkr6cOIMD9

Vaccine Efficacy in Patients with Seronegative SpA Vaccine efficacy remains an important topic at #ACR22 given the ongo

Social Author Name
Dr. John Cush
Tweet Content
Vaccine Efficacy in Patients with Seronegative SpA Vaccine efficacy remains an important topic at #ACR22 given the ongoing COVID-19 health crisis, current influenza season, and recently published 2022 ACR guidelines. https://t.co/2PHrJYV8Om Written by Dr. Sims ( @DrCassySims) https://t.co/hUFnPIDzUU

Treatment Persistence and Switching Patterns of an Adalimumab Biosimilar Dr. Julian Segan ( @JulianSegan) discusses

Social Author Name
Dr. John Cush
Tweet Content
Treatment Persistence and Switching Patterns of an Adalimumab Biosimilar Dr. Julian Segan ( @JulianSegan) discusses Abstract 1425 at #ACR22 Abstract 1425: Treatment Persistence and Switching Patterns of AMGEVITA® in German Patients with RD https://t.co/MpNnrqYxGJ https://t.co/Sfi1kxOXLX
Subscribe to
×